Literature DB >> 17196950

Proteomic analysis of rat cortical neurons after fluoxetine treatment.

Daniela Cecconi1, Silvia Mion, Hubert Astner, Enrico Domenici, Pier Giorgio Righetti, Lucia Carboni.   

Abstract

The known neurochemical effect of most currently available antidepressants is the enhancement of the synaptic levels of monoamine neurotransmitters. However, the existence of other mechanisms has been suggested to justify the significant delay between the modulation of the monoaminergic system and the clinical effects. In order to investigate the effects of the antidepressant fluoxetine (a prototypical serotonin selective re-uptake inhibitor) and to improve the understanding of its mechanism of action, we performed a proteomic investigation in rat primary cortical neurons exposed sub-chronically to this antidepressant. Cortical neurons were treated for 3 days with 1 microM fluoxetine or vehicle. Protein extracts were processed for 2D gel characterization. Image analysis allowed the identification of six proteins differently expressed by more than 100% and seven proteins differently expressed by more than 50% (P<0.05). Nine proteins were identified by mass spectrometry. Among them, cyclophilin A, 14-3-3 protein z/delta and GRP78 are involved in neuroprotection, in serotonin biosynthesis and in axonal transport, respectively. This study showed that the primary culture of cortical neurons is a suitable system for studying the effects of fluoxetine action and may contribute to improve the understanding of fluoxetine psychotherapeutic action and the mechanisms mediating the long-term effects of this antidepressant treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17196950     DOI: 10.1016/j.brainres.2006.12.008

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  Involvement of PI3K/Akt/FoxO3a and PKA/CREB Signaling Pathways in the Protective Effect of Fluoxetine Against Corticosterone-Induced Cytotoxicity in PC12 Cells.

Authors:  Bingqing Zeng; Yiwen Li; Bo Niu; Xinyi Wang; Yufang Cheng; Zhongzhen Zhou; Tingting You; Yonggang Liu; Haitao Wang; Jiangping Xu
Journal:  J Mol Neurosci       Date:  2016-07-13       Impact factor: 3.444

Review 2.  The potential of biomarkers in psychiatry: focus on proteomics.

Authors:  Izabela Sokolowska; Armand G Ngounou Wetie; Kelly Wormwood; Johannes Thome; Costel C Darie; Alisa G Woods
Journal:  J Neural Transm (Vienna)       Date:  2013-12-20       Impact factor: 3.575

3.  Whole-transcriptome microarray analysis reveals regulation of Rab4 by RBM5 in neurons.

Authors:  Travis C Jackson; Shawn E Kotermanski; Patrick M Kochanek
Journal:  Neuroscience       Date:  2017-08-15       Impact factor: 3.590

4.  Pharmacologically diverse antidepressants facilitate TRKB receptor activation by disrupting its interaction with the endocytic adaptor complex AP-2.

Authors:  Senem Merve Fred; Liina Laukkanen; Cecilia A Brunello; Liisa Vesa; Helka Göös; Iseline Cardon; Rafael Moliner; Tanja Maritzen; Markku Varjosalo; Plinio C Casarotto; Eero Castrén
Journal:  J Biol Chem       Date:  2019-10-20       Impact factor: 5.157

Review 5.  Target identification for CNS diseases by transcriptional profiling.

Authors:  C Anthony Altar; Marquis P Vawter; Stephen D Ginsberg
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

6.  Fluoxetine increases plasticity and modulates the proteomic profile in the adult mouse visual cortex.

Authors:  L Ruiz-Perera; M Muniz; G Vierci; N Bornia; L Baroncelli; A Sale; F M Rossi
Journal:  Sci Rep       Date:  2015-07-24       Impact factor: 4.379

7.  Profiling of Proteins Regulated by Venlafaxine during Neural Differentiation of Human Cells.

Authors:  Mi Sook Doh; Dal Mu Ri Han; Dong Hoon Oh; Seok Hyeon Kim; Mi Ran Choi; Young Gyu Chai
Journal:  Psychiatry Investig       Date:  2015-01-12       Impact factor: 2.505

8.  Time-dependent biphasic modulation of human BDNF by antidepressants in neuroblastoma cells.

Authors:  Lorena Donnici; Ettore Tiraboschi; Daniela Tardito; Laura Musazzi; Giorgio Racagni; Maurizio Popoli
Journal:  BMC Neurosci       Date:  2008-07-05       Impact factor: 3.288

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.